Metabolic Syndrome in PCOS: Precursors and Interventions

Completed · Not applicable · Has a placebo group

Conditions studied: Polycystic Ovary Syndrome, Metabolic Syndrome

In brief

The purpose of this study is to investigate the metabolic effects of anti-androgens and oral contraceptive pills (OCPs), compared with placebo, in the treatment of women with PCOS. We hypothesized that controlling elevated androgen levels with either anti-androgens or OCPs would produce improvement in metabolic markers in PCOS women and would reduce their long term metabolic risk.

Key facts

Study ID

NCT00442689

Run by

Northwestern University

People needed

97

Starts

2006-07-01

Expected to finish

2012-11-01

Last updated by the study team

2014-06-06

Who can join

Age: 18 and older, up to 35. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• 6 periods or fewer per year
• Overweight
• All ethnicities

You may not qualify if…

• Diabetes
• Heart Disease
• Chronic illness
• Regular Smokers
• Current use of Birth Control Pills, Patch, Ring, Depo

Where it is running

• Northwestern Memorial Hospital — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.